Discovery of a new inhibitor targeting PD-L1 for cancer immunotherapy

Autor: Xiao-Jun Yao, Wang Fengling, Shaoping Ji, Yuwei Wang, Huanxiang Liu, Shuang Wang, Han Jianting, Yong-Xing He, Haiyang Zhong, Zhitong Bing, Wenling Ye, Yongchang Zhu

Publikováno v: Neoplasia (New York, N.Y.)
Neoplasia: An International Journal for Oncology Research, Vol 23, Iss 3, Pp 281-293 (2021)

Blockade of the PD-1/PD-L1 immunologic checkpoint using monoclonal antibodies has provided breakthrough therapies against cancer in the recent years. Nevertheless, intrinsic disadvantages of therapeutic antibodies may limit their applications. Thus,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::546f3cf747a66f334993c223280baf2d
https://pubmed.ncbi.nlm.nih.gov/33529880